Skip to content

Prepaid expenses at other companies

Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
Arrowhead Research logo
Arrowhead ResearchARWR
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+31.9%
Enterprise value$1.07B+26.9%
P/S13.5×-10.1×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's prepaid expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's prepaid expenses?
MeiraGTx Holdings plc (MGTX) reported prepaid expenses of $6.03M in Q1 2026.
How has MeiraGTx Holdings plc's prepaid expenses changed year-over-year?
MeiraGTx Holdings plc's prepaid expenses decreased by 12.9% year-over-year, from $6.93M to $6.03M.
What is the long-term trend for MeiraGTx Holdings plc's prepaid expenses?
Over 5 years (2020 to 2025), MeiraGTx Holdings plc's prepaid expenses has grown at a -3.2% compound annual growth rate (CAGR), from $7.08M to $6.02M.